#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neuroblastoma Synovitis Chronic granulomatous disease Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Neuronal ceroid lipofuscinosis Acquired C1 inhibitor deficiency ROHHAD syndrome Progressive multifocal leukoencephalopathy Anal cancer recurrent Cytomegalovirus infection Chronic hepatitis B Haemophilia Progressive familial intrahepatic cholestasis Brain injury Rett syndrome More trials…

    Learn about Rare Diseases

    Ornithine transcarbamoylase deficiency – Life with Disease Indolent systemic mastocytosis – Treatment Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Life with Disease Idiopathic inflammatory myopathy – Diagnostics Rhabdomyosarcoma Urea cycle disorder – Life with Disease Familial haemophagocytic lymphohistiocytosis Behcet’s syndrome – Diagnostics Shprintzen-Goldberg syndrome – Treatment Fabry’s disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Desloratadine Siremadlin PEGZILARGINASE Guanfacine Protein C GSKVX000000048111 SIGVOTATUG VEDOTIN Xanomeline Tartrate Anastrozole Other Immunosuppressants Botaretigene Sparoparvovec GRAPHITE Viltolarsen Lolium Perenne Pollen Extract Betaxolol Dcc-3116 Dexamethasone HAFNIUM OXIDE Nadunolimab Colistimethate Sodium More therapies…

    Learn about Your Condition

    Juvenile psoriatic arthritis Hypotonia Adenocarcinoma Lysosomal storage disorder Polycystic ovarian syndrome Renal cancer metastatic Tumour thrombosis Hypotransferrinaemia Fabry's disease Bladder cancer Asplenia Deafness traumatic Malformation venous Rhinitis allergic Acute hepatic failure More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Effectiveness of Beltavac with Grass Pollen Extract for Patients with Allergic Rhinoconjunctivitis and Possible Asthma

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Seasonal allergy
    Investigated Drugs:
    • Allergenic Extract Of Grass Pollen Mixture: Dactylis Glomerata, Festuca Pratensis, Lolium Perenne, Phleum Pratense And Poa Pratensis (1:1:1:1:1), Polymerised
    • Placebo
    Poland Spain

  • Study of SYM024, SYM023, and SYM025 in Adults with Advanced Non-Small Cell Lung Cancer (NSCLC) with High PD-L1 Expression

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    • Sym023
    • Sym024
    • Sym025
    Austria Belgium France Hungary Italy Romania +1

  • Study on Pain Relief After Breast Cancer Surgery: Comparing Liposomal Bupivacaine and Levobupivacaine in Patients Undergoing Mastectomy

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Procedural pain
    Investigated Drugs:
    • Bupivacaine
    • Bupivacaine Hydrochloride, Anhydrous
    • Levobupivacaine
    The Netherlands

  • Study on the Safety and Effectiveness of AL8326 for Patients with Small Cell Lung Cancer Needing Second-Line Treatment

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Small cell lung cancer
    Investigated Drugs:
    • Al8326
    Italy Spain

  • Study on the Safety and Tolerability of CEB-01 in Patients with Pancreatic Cancer

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • 7-Ethyl-10-Hydroxycamptothecin
    Spain

  • Study on Cryotherapy and Tirbanibulin for Treating Actinic Keratosis on the Scalp and Forehead in Patients Aged 18 and Older

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Tirbanibulin
    France
Previous Page
1 … 877 878 879 880 881 … 1,675
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!